Skip to main navigation Skip to search Skip to main content

A Randomised Placebo-controlled Multicentre Phase Ii Trial of Erlotinib Plus Whole Brain Radiotherapy for Patients with Advanced Non-small Cell Lung Cancer with Multiple Brain Metastases (tactic)

  • SM Lee
  • , C Lewanski
  • , N Counsell
  • , C Ottensmeier
  • , AT Bates
  • , N Patel
  • , C Wadsworth
  • , Y Ngai
  • , A Hackshaw
  • , C Faivre-Finn

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S298-S299
Number of pages2
JournalJournal of Thoracic Oncology
Volume8
Publication statusPublished - Nov 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Brain Metastases
  • Erlotinib
  • Randomised
  • WBRT

Cite this